Vaccines for leishmaniasis: from proteome to vaccine candidates.
Schroeder, Juliane; Aebischer, Toni.
; 7 Suppl: 10-5, 2011.
Artigo em Inglês | MEDLINE | ID: mdl-21245661
How to master the host immune system? Leishmania parasites have the solutions!
Overview of dendritic cell-based vaccine development for leishmaniasis.
Nanobiotechnologic approach to a promising vaccine prototype for immunisation against leishmaniasis: a fast and effective method to incorporate GPI-anchored proteins of Leishmania amazonensis into liposomes.
Role of pro-inflammatory cytokine IL-17 in Leishmania pathogenesis and in protective immunity by Leishmania vaccines.
Specificity of anti-saliva immune response in mice repeatedly bitten by Phlebotomus sergenti.
Not All Antigens Are Created Equally: Progress, Challenges, and Lessons Associated with Developing a Vaccine for Leishmaniasis.
Vaccine candidates against leishmania under current research.
Cross-protective efficacy from a immunogen firstly identified in Leishmania infantum against tegumentary leishmaniasis.
Leishmaniasis and various immunotherapeutic approaches.
Identifying vaccine targets for anti-leishmanial vaccine development.